Free Trial

SQZ Biotechnologies (SQZ) Insider Trading & Ownership

SQZ Biotechnologies logo
$0.03 0.00 (0.00%)
(As of 12/17/2024 ET)

SQZ Biotechnologies (NYSE:SQZ) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
16.00%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
$50,406.40
Number Of
Insiders Selling
(Last 3 Years)
1
Amount Of
Insider Selling
(Last 3 Years)
$3,929.40
Get SQZ Insider Trade Alerts

Want to know when executives and insiders are buying or selling SQZ Biotechnologies stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

SQZ Insider Buying and Selling by Quarter

SQZ Biotechnologies Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/15/2022Richard CapassoInsiderSell118$33.30$3,929.40  
5/25/2022Klavs F JensenDirectorBuy1,432$35.20$50,406.40  
(Data available from 1/1/2013 forward)

SQZ Insider Trading Activity - Frequently Asked Questions

The list of insiders at SQZ Biotechnologies includes Klavs F Jensen, and Richard Capasso. Learn more on insiders at SQZ.

16.00% of SQZ Biotechnologies stock is owned by insiders. Learn more on SQZ's insider holdings.

SQZ Biotechnologies Key Executives

  • Dr. Howard Bernstein M.D. (Age 66)
    Ph.D., Interim CEO & Director
    Compensation: $552.14k
  • Mr. Lawrence J. Knopf Esq. (Age 61)
    Gen. Counsel
    Compensation: $512.38k
  • Dr. Marshelle Smith Warren M.D. (Age 60)
    Chief Medical Officer
    Compensation: $476.27k
  • Dr. Robert S. Langer Jr. (Age 74)
    Ph.D., Sc.D., SCD, Co-Founder & Member of Scientific Advisory Board
  • Mr. Richard V. Capasso CPA (Age 61)
    Chief Accounting Officer
  • Mr. David First (Age 59)
    Chief People Officer
  • Ipsita Roymoulik Ph.D.
    Sr. VP of CMC & QUALITY


This page (NYSE:SQZ) was last updated on 12/18/2024 by MarketBeat.com Staff
From Our Partners